COA Response to Senate RFI on 340B Drug Pricing Program
On behalf of the Board of Directors of the Community Oncology Alliance (“COA”), we are submitting this response to the Senate RFI seeking input on the 340B Drug Pricing Program (“340B”).
COA Response to Senate RFI on 340B Drug Pricing Program
On behalf of the Board of Directors of the Community Oncology Alliance (“COA”), we are submitting this response to the Senate RFI seeking input on the 340B Drug Pricing Program (“340B”).
